PEN - Penumbra, Inc.

...

Available for logged in users only.

The multiple price alert feature will smartly add or remove $1 if your alert was hit.
It's only available if you are logged in, a V.I.P. member or if you are using the AI chrome extension.

Contact us via Twitter if you are interested in trying it out.

• Penumbra Q1 results beat estimates, co raises FY 2023 revenue guidance
• Penumbra Q1 2023 Earnings Preview
• Penumbra Non-GAAP EPS of $0.16 beats by $0.01, revenue of $221.22M beats by $4.19M
• Penumbra Q4 2022 Earnings Preview
• Stocks with earnings at risk from UBS
• Penumbra's new thrombosis system will drive growth in underpenetrated markets: Wells Fargo
• Med-tech companies could make sense for health care investors in 2023 as defensive sector
• Penumbra upgraded at Citi given upcoming vascular device launches
• Penumbra Non-GAAP EPS of $0.01 in-line, revenue of $213.7M beats by $1.38M
• Penumbra Q3 2022 Earnings Preview
• Penumbra cut to Neutral at Citi on macro concerns
• Penumbra, Asahi team up to bring blood clot removing device Indigo to Japan
• Penumbra upgraded at Needham citing growth acceleration ahead
• Shockwave Medical gains on vague takeover speculation
• Penumbra stock rises ~11% after announcing European launch of catheters for stroke care
• Penumbra GAAP EPS of -$0.10 misses by $0.11, revenue of $208.34M beats by $2.1M
• Penumbra Q2 2022 Earnings Preview
• Penumbra gains as RBC initiates at Outperform with 59% upside
• Penumbra Non-GAAP EPS of -$0.01 misses by $0.05, revenue of $203.9M beats by $8.51M
• Penumbra Q1 2022 Earnings Preview